ATLANTA - May 8, 2017 - Acuity Brands, Inc. (AYI) announced today the availability of the Gotham® MYO Series, a multifunctional luminaire system that delivers up to three layers of light - ambient, ...
The merged entity, Opko, has an initial focus on drugs for ophthalmic disorders. Acuity Pharmaceuticals, Froptix, and eXegenics will merge to form Opko. The new biopharmaceutical company plans to list ...
ATLANTA, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Acuity Brands, Inc. (NYSE: AYI) (the “Company” or “Acuity”), a market-leading industrial technology company, has reached a definitive agreement to acquire ...
Acuity has a history of delivering consistently high returns on invested capital (ROIC) above 30%, indicating efficient use of capital to generate profits. The trend towards energy-efficient lighting ...
ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Acuity Brands, Inc.’s (NYSE: AYI) corporate name is changing from Acuity Brands, Inc. to Acuity Inc. effective March 26, 2025. Acuity will continue to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback